Q5119 Inj ruxience, 10 mg

Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 150 units per day (practitioner), rationale: Prescribing Information